Supernus Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Supernus Pharmaceuticals Inc cash flow-to-debt ratio. Supernus Pharmaceuticals Inc (SUPN) has a Cash Flow-to-Debt Ratio of -0.01x as of June 2026, meaning its operating cash flow of $-4.81 Million could theoretically repay 0% of its total liabilities ($396.88 Million) in one year. Check Supernus Pharmaceuticals Inc (SUPN) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Supernus Pharmaceuticals Inc (2008–2025)
Cash flow-to-debt ratio of Supernus Pharmaceuticals Inc from 2008 to 2025. Historical debt coverage capacity for Supernus Pharmaceuticals Inc across 18 annual periods. Check SUPN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Supernus Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2008–2025)
Supernus Pharmaceuticals Inc cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Supernus Pharmaceuticals Inc. For the full cash flow conversion analysis, see SUPN operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $47.33 Million | $390.93 Million | ▼ -76.6% |
| 2024 | 0.52x | $171.95 Million | $332.34 Million | ▲ +65.9% |
| 2023 | 0.31x | $111.08 Million | $356.16 Million | ▲ +117.9% |
| 2022 | 0.14x | $116.83 Million | $816.30 Million | ▼ -1.7% |
| 2021 | 0.15x | $127.13 Million | $873.30 Million | ▼ -20.1% |
| 2020 | 0.18x | $138.40 Million | $759.24 Million | ▼ -28.1% |
| 2019 | 0.25x | $143.13 Million | $564.85 Million | ▲ +3.1% |
| 2018 | 0.25x | $128.99 Million | $524.79 Million | ▼ -66.3% |
| 2017 | 0.73x | $114.64 Million | $156.98 Million | ▲ +28.8% |
| 2016 | 0.57x | $66.81 Million | $117.81 Million | ▲ +23.3% |
| 2015 | 0.46x | $32.12 Million | $69.86 Million | ▲ +293.4% |
| 2014 | 0.12x | $7.73 Million | $66.15 Million | ▲ +115.6% |
| 2013 | -0.75x | $-57.95 Million | $77.53 Million | ▲ +42.3% |
| 2012 | -1.30x | $-47.20 Million | $36.42 Million | ▼ -58.6% |
| 2011 | -0.82x | $-36.19 Million | $44.29 Million | ▼ -129.3% |
| 2010 | -0.36x | $-32.54 Million | $91.33 Million | ▼ -1264.2% |
| 2009 | 0.03x | $2.63 Million | $86.06 Million | ▲ +108.7% |
| 2008 | -0.35x | $-29.65 Million | $83.88 Million | — |